|
US4426330A
(en)
|
1981-07-20 |
1984-01-17 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
|
US4534899A
(en)
|
1981-07-20 |
1985-08-13 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
GB8824593D0
(en)
|
1988-10-20 |
1988-11-23 |
Royal Free Hosp School Med |
Liposomes
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5665710A
(en)
|
1990-04-30 |
1997-09-09 |
Georgetown University |
Method of making liposomal oligodeoxynucleotide compositions
|
|
JP3220180B2
(ja)
|
1991-05-23 |
2001-10-22 |
三菱化学株式会社 |
薬剤含有タンパク質結合リポソーム
|
|
JP3351476B2
(ja)
|
1993-01-22 |
2002-11-25 |
三菱化学株式会社 |
リン脂質誘導体及びそれを含有するリポソーム
|
|
AU6044994A
(en)
|
1993-02-19 |
1994-09-14 |
Nippon Shinyaku Co. Ltd. |
Glycerol derivative, device and pharmaceutical composition
|
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
CA2137297C
(en)
|
1993-12-06 |
2000-04-18 |
Tsuyoshi Miyazaki |
Reactive vesicle and functional substance-fixed vesicle
|
|
US5543152A
(en)
|
1994-06-20 |
1996-08-06 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
|
US5756122A
(en)
|
1995-06-07 |
1998-05-26 |
Georgetown University |
Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
|
|
ATE247971T1
(de)
|
1995-08-01 |
2003-09-15 |
Novartis Erfind Verwalt Gmbh |
Liposomale oligonukleotidzusammensetzungen
|
|
US5858397A
(en)
|
1995-10-11 |
1999-01-12 |
University Of British Columbia |
Liposomal formulations of mitoxantrone
|
|
US5998203A
(en)
|
1996-04-16 |
1999-12-07 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
|
|
US5994316A
(en)
|
1996-02-21 |
1999-11-30 |
The Immune Response Corporation |
Method of preparing polynucleotide-carrier complexes for delivery to cells
|
|
US6218108B1
(en)
|
1997-05-16 |
2001-04-17 |
Research Corporation Technologies, Inc. |
Nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor
|
|
EP0975798A1
(en)
|
1997-03-11 |
2000-02-02 |
Yale University |
Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
|
|
WO1999001579A1
(en)
|
1997-07-01 |
1999-01-14 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
|
US5976849A
(en)
|
1998-02-05 |
1999-11-02 |
Zeneca Limited |
Human E3 ubiquitin protein ligase
|
|
WO2000053722A2
(en)
|
1999-03-10 |
2000-09-14 |
Phogen Limited |
Delivery of nucleic acids and proteins to cells
|
|
CN100523215C
(zh)
|
2000-12-01 |
2009-08-05 |
马普科技促进协会 |
介导rna干涉的小rna分子
|
|
US20030064385A1
(en)
|
2001-05-16 |
2003-04-03 |
Dressman Marlene Michelle |
Genes expressed in breast cancer as prognostic and therapeutic targets
|
|
EP1478655A4
(en)
|
2001-12-31 |
2006-05-10 |
Algos Therapeutics Inc |
METHODS AND SUBSTANCES FOR ENAC-BETA MODULATION
|
|
JP4709545B2
(ja)
|
2002-07-26 |
2011-06-22 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
修飾された低分子干渉ｒｎａ分子および使用方法
|
|
JP2004121218A
(ja)
|
2002-08-06 |
2004-04-22 |
Jenokkusu Soyaku Kenkyusho:Kk |
気管支喘息または慢性閉塞性肺疾患の検査方法
|
|
EP2305813A3
(en)
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
US20060275770A1
(en)
|
2002-11-27 |
2006-12-07 |
Daniel Bednarik |
Heart failure gene determination and therapeutic screening
|
|
DE10305213A1
(de)
|
2003-02-07 |
2004-08-26 |
Florian Prof. Dr.med. Lang |
Verwendung eines neuen Polymorphismus im hsgk1-Gen zur Diagnose der Hypertonie und Verwendung der sgk-Genfamilie zur Diagnose und Therapie des Long-Q/T-Syndroms
|
|
WO2004089423A2
(en)
|
2003-03-31 |
2004-10-21 |
University Of Iowa Research Foundation |
Pharmico-gene theraphy of epithelial sodium channel associated disoders
|
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
|
AU2003224132A1
(en)
|
2003-04-24 |
2004-11-19 |
Galapagos Genomics N.V. |
Effective sirna knock-down constructs
|
|
US20050256071A1
(en)
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
|
CA2566286A1
(en)
|
2004-05-11 |
2005-12-08 |
Rnai Co., Ltd. |
Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
|
|
US20060166234A1
(en)
|
2004-11-22 |
2006-07-27 |
Barbara Robertson |
Apparatus and system having dry control gene silencing compositions
|
|
EP1824872B1
(en)
|
2004-12-14 |
2012-02-08 |
Alnylam Pharmaceuticals Inc. |
Rnai modulation of mll-af4 and uses thereof
|
|
EP1948674A4
(en)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
|
|
CN101500548A
(zh)
|
2006-08-18 |
2009-08-05 |
弗·哈夫曼-拉罗切有限公司 |
用于体内递送多核苷酸的多缀合物
|
|
US20110150897A1
(en)
|
2006-10-11 |
2011-06-23 |
Meyer Thomas F |
Influenza targets
|
|
AR066984A1
(es)
|
2007-06-15 |
2009-09-23 |
Novartis Ag |
Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia)
|
|
KR20110095391A
(ko)
|
2008-11-26 |
2011-08-24 |
머크 샤프 앤드 돔 코포레이션 |
짧은 간섭 핵산 (ｓｉＮＡ)을 사용한 상피 나트륨 채널 (ＥＮａＣ) 유전자 발현의 ＲＮＡ 간섭 매개 억제
|
|
US20130023578A1
(en)
*
|
2009-12-31 |
2013-01-24 |
Samyang Biopharmaceuticals Corporation |
siRNA for inhibition of c-Met expression and anticancer composition containing the same
|
|
PH12012501596A1
(en)
|
2010-02-24 |
2017-02-03 |
Arrowhead Res Corporation |
Compositions for targeted delivery of sirna
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
CA2842039A1
(en)
|
2011-08-26 |
2013-03-07 |
Arrowhead Research Corporation |
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
|
|
MX2014001965A
(es)
|
2012-04-18 |
2014-03-31 |
Arrowhead Res Corp |
Polimeros de poli(acrilato) para suministro de acido nucleico in vivo.
|
|
US9574195B2
(en)
*
|
2013-07-02 |
2017-02-21 |
Indian Council Of Medical Research |
RNAi agent for inhibition of Chikungunya virus
|
|
JOP20160211B1
(ar)
*
|
2015-10-01 |
2021-08-17 |
Arrowhead Pharmaceuticals Inc |
تراكيب وأساليب لتثبيط تعبير جيني للـ lpa
|
|
AU2017354041B2
(en)
|
2016-11-01 |
2024-02-01 |
Arrowhead Pharmaceuticals, Inc. |
Alpha-V beta-6 integrin ligands and uses thereof
|
|
TN2019000308A1
(en)
*
|
2017-07-06 |
2021-05-07 |
Arrowhead Pharmaceuticals Inc |
RNAi AGENTS FOR INHIBITING EXPRESSION OF ALPHA-ENaC AND METHODS OF USE
|
|
SG11202002967SA
(en)
*
|
2017-11-01 |
2020-05-28 |
Arrowhead Pharmaceuticals Inc |
Integrin ligands and uses thereof
|
|
CN120247964A
(zh)
*
|
2018-02-17 |
2025-07-04 |
箭头药业股份有限公司 |
三炔连接剂和使用方法
|